Showing results (71-80 of 169) with videos related to
Sort By:
Pageof 17
Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.Iscience|October 11, 2024
Deciphering the role of endothelial granulocyte macrophage-CSF in chronic inflammation associated with HIVSoumya Panigrahi, Elizabeth Mayne, Susan Louw, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohortNirzari Parikh, Will Dampier, Rui Feng, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapyScott L Butler, Hernan Valdez, Michael Westby, et al.Journal of Virology|March 30, 2018
Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNAZachary Strongin, Radwa Sharaf, D Jake VanBelzen, et al.Human Vaccines & Immunotherapeutics|November 27, 2014
Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccineBrian Latimer, Roberta Toporovski, Jian Yan, et al.Science Advances|December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102Keith Henry, David Katzenstein, Deborah Weng Cherng, et al.Plos One|May 20, 2016
HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed PatientsWill Dampier, Michael R Nonnemacher, Joshua Mell, et al.Pageof 17